Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Wichmann

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
BMC Medical Research Methodology|June 3, 2014
Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal toolsThomas Harder, Anja Takla, Eva Rehfuess, et al.
Pharmacoeconomics|October 19, 2015
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics CommunityBernhard Ultsch, Oliver Damm, Philippe Beutels, et al.
Plos One|October 13, 2011
Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011Yanina Balabanova, Andreas Gilsdorf, Silke Buda, et al.
Malaria Journal|November 9, 2002
Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in EuropeTomas Jelinek, Gabriele Peyerl-Hoffmann, Nikolai Mühlberger, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2025
Effectiveness of COVID-19 vaccines against post-COVID-19 condition/long COVID: systematic review and meta-analysisCaroline Peine, Anna Stoliaroff-Pepin, Ulrich Reinacher, et al.
Reviews in Medical Virology|February 2, 2022
Systematic review of the efficacy, effectiveness and safety of recombinant haemagglutinin seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of ageEamon O Murchu, Laura Comber, Karen Jordan, et al.
Reviews in Medical Virology|February 10, 2022
Systematic review of the efficacy, effectiveness and safety of MF59<sup>®</sup> adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of ageEamon O Murchu, Laura Comber, Karen Jordan, et al.
The Journal of Infectious Diseases|October 13, 2004
Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in EuropeOle Wichmann, Nikolai Muehlberger, Tomas Jelinek, et al.
BMC Public Health|July 18, 2018
Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60Cornelia Betsch, Constanze Rossmann, Mathias W Pletz, et al.
Reviews in Medical Virology|February 9, 2022
Systematic review of the efficacy, effectiveness and safety of cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of ageKaren Jordan, Eamon O Murchu, Laura Comber, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
BMC Medical Research Methodology|June 3, 2014
Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal toolsThomas Harder, Anja Takla, Eva Rehfuess, et al.
Pharmacoeconomics|October 19, 2015
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics CommunityBernhard Ultsch, Oliver Damm, Philippe Beutels, et al.
Plos One|October 13, 2011
Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011Yanina Balabanova, Andreas Gilsdorf, Silke Buda, et al.
Malaria Journal|November 9, 2002
Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in EuropeTomas Jelinek, Gabriele Peyerl-Hoffmann, Nikolai Mühlberger, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2025
Effectiveness of COVID-19 vaccines against post-COVID-19 condition/long COVID: systematic review and meta-analysisCaroline Peine, Anna Stoliaroff-Pepin, Ulrich Reinacher, et al.
Reviews in Medical Virology|February 2, 2022
Systematic review of the efficacy, effectiveness and safety of recombinant haemagglutinin seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of ageEamon O Murchu, Laura Comber, Karen Jordan, et al.
Reviews in Medical Virology|February 10, 2022
Systematic review of the efficacy, effectiveness and safety of MF59<sup>®</sup> adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of ageEamon O Murchu, Laura Comber, Karen Jordan, et al.
The Journal of Infectious Diseases|October 13, 2004
Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in EuropeOle Wichmann, Nikolai Muehlberger, Tomas Jelinek, et al.
BMC Public Health|July 18, 2018
Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60Cornelia Betsch, Constanze Rossmann, Mathias W Pletz, et al.
Reviews in Medical Virology|February 9, 2022
Systematic review of the efficacy, effectiveness and safety of cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of ageKaren Jordan, Eamon O Murchu, Laura Comber, et al.
Pageof 18